Referências
Principais artigos
Centers for Disease Control and Prevention. Highly pathogenic avian influenza A(H5N1) virus in animals: interim recommendations for prevention, monitoring, and public health investigations. Jun 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. Sep 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. Interim guidance on specimen collection and testing for patients with suspected infection with novel influenza A viruses associated with severe disease or with the potential to cause severe disease in humans. Sep 2024 [internet publication].Texto completo
World Health Organization. Clinical practice guidelines for influenza. Sep 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. Interim guidance for follow-up of close contacts of persons infected with novel influenza A viruses associated with severe human disease or with potential to cause severe human disease, and use of antiviral medications for post-exposure prophylaxis. Aug 2024 [internet publication].Texto completo
Artigos de referência
1. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med. 2005 Jan 27;352(4):333-40.Texto completo Resumo
2. Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet. 2008 Apr 26;371(9622):1427-34. Resumo
3. Centers for Disease Control and Prevention. Current H5N1 bird flu situation in dairy cows. Oct 2024 [internet publication].Texto completo
4. Skowronski DM, Tweed SA, Petric M, et al. Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada. J Infect Dis. 2006 Mar 15;193(6):899-900. Resumo
5. Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet. 1999 Sep 11;354(9182):916-7. Resumo
6. Uyeki TM, Chong YH, Katz JM, et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis. 2002 Feb;8(2):154-9.Texto completo Resumo
7. Eurosurveillance editorial team. Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill. 2007 May 31;12(5):E070531.Texto completo Resumo
8. Kurtz J, Manvell RJ, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet. 1996 Sep 28;348(9031):901-2. Resumo
9. Zhuang Y, Wang M, Liang L, et al. First known human death after infection with the avian influenza A/H3N8 virus: Guangdong Province, China, March 2023. Clin Infect Dis. 2024 Mar 20;78(3):646-50.Texto completo Resumo
10. Qi X, Qiu H, Hao S, et al. Human infection with an avian-origin influenza A (H10N3) virus. N Engl J Med. 2022 Mar 17;386(11):1087-8.Texto completo Resumo
11. Tong XC, Weng SS, Xue F, et al. First human infection by a novel avian influenza A(H7N4) virus. J Infect. 2018 Sep;77(3):249-57. Resumo
12. Tweed SA, Skowronski DM, David ST, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis. 2004 Dec;10(12):2196-9.Texto completo Resumo
13. Nguyen-Van-Tam JS, Nair P, Acheson P, et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill. 2006 May 4;11(5):E060504.Texto completo Resumo
14. Pan M, Gao R, Lv Q, et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings. J Infect. 2016 Jan;72(1):52-9. Resumo
15. Yang ZF, Mok CK, Peiris JS, et al. Human infection with a novel avian influenza A (H5N6) virus. N Engl J Med. 2015 Jul 30;373(5):487-9.Texto completo Resumo
16. World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization H5N1 Evolution Working Group. Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses. Influenza Other Respir Viruses. 2014 May;8(3):384-8.Texto completo Resumo
17. World Health Organization. Evolution of the influenza A(H5) haemagglutinin: WHO/OIE/FAO H5 Working Group reports a new clade designated 2.3.4.4. Jan 2015 [internet publication].Texto completo
18. Smith GJ, Donis RO; World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5 Evolution Working Group. Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014. Influenza Other Respir Viruses. 2015 Sep;9(5):271-6.Texto completo Resumo
19. World Health Organization. Genetic and antigenic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness. Feb 2023 [internet publication].Texto completo
20. Centers for Disease Control and Prevention. Technical report: June 2024 highly pathogenic avian influenza A(H5N1) viruses. Jun 2024 [internet publication].Texto completo
21. World Health Organization. Assessment of risk associated with recent influenza A(H5N1) clade 2.3.4.4b viruses. Dec 2022 [internet publication].Texto completo
22. Centers for Disease Control and Prevention. H5 bird flu: current situation. Oct 2024 [internet publication].Texto completo
23. World Health Organization. Genetic and antigenic characteristics of clade 2.3.4.4b A(H5N1) viruses identified in dairy cattle in the United States of America. May 2024 [internet publication].Texto completo
24. Centers for Disease Control and Prevention. Technical update: summary analysis of the genetic sequence of a highly pathogenic avian influenza A(H5N1) virus identified in a human in Michigan. May 2024 [internet publication].Texto completo
25. World Health Organization. Update on human cases of highly pathogenic avian influenza A(H5N1) virus infection, 2010. Wkly Epidemiol Rec. 2011 Apr 22;86(17):161-6.Texto completo Resumo
26. Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis. 2009 Jul 15;49(2):279-90.Texto completo Resumo
27. de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005 Feb 17;352(7):686-91.Texto completo Resumo
28. Rajabali N, Lim T, Sokolowski C, et al. Avian influenza A (H5N1) infection with respiratory failure and meningoencephalitis in a Canadian traveller. Can J Infect Dis Med Microbiol. 2015 Jul-Aug;26(4):221-3.Texto completo Resumo
29. Kandeel A, Manoncourt S, Abd el Kareem E, et al. Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006-2009. Emerg Infect Dis. 2010 Jul;16(7):1101-7.Texto completo Resumo
30. International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). Outbreak of mild respiratory disease caused by H5N1 and H9N2 infections among young children in Dhaka, Bangladesh, 2011. Health Sci Bulletin. 2011;9:1-12.Texto completo
31. Oner AF, Dogan N, Gasimov V, et al. H5N1 avian influenza in children. Clin Infect Dis. 2012 Jul;55(1):26-32.Texto completo Resumo
32. Shinde V, Hanshaoworakul W, Simmerman JM, et al. A comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006. PLoS One. 2011 Apr 29;6(4):e14809.Texto completo Resumo
33. Chan PK. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002 May 1;34(suppl 2):S58-64.Texto completo Resumo
34. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004 Feb 21;363(9409):617-9.Texto completo Resumo
35. World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2024, 19 July 2024. Jul 2024 [internet publication].Texto completo
36. UK Health Security Agency. Avian influenza (influenza A H5N1): risk to human health. Jul 2024 [internet publication].Texto completo
37. Centers for Disease Control and Prevention. Highly pathogenic avian influenza A(H5N1) virus in animals: interim recommendations for prevention, monitoring, and public health investigations. Jun 2024 [internet publication].Texto completo
38. Centers for Disease Control and Prevention. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. Sep 2024 [internet publication].Texto completo
39. World Health Organization. Disease outbreak news: avian influenza A(H5N1) - United States of America. Apr 2024 [internet publication].Texto completo
40. Centers for Disease Control and Prevention. Highly pathogenic avian influenza A (H5N1) virus infection reported in a person in the U.S. Apr 2024 [internet publication].Texto completo
41. Centers for Disease Control and Prevention. CDC reports second human case of H5 bird flu tied to dairy cow outbreak. May 2024 [internet publication].Texto completo
42. Centers for Disease Control and Prevention. CDC confirms second human H5 bird flu case in Michigan; third case tied to dairy outbreak. May 2024 [internet publication].Texto completo
43. Centers for Disease Control and Prevention. CDC reports fourth human case of H5 bird flu tied to dairy cow outbreak. Jul 2024 [internet publication].Texto completo
44. Drehoff CC, White EB, Frutos AM. Cluster of influenza A(H5) cases associated with poultry exposure at two facilities — Colorado, July 2024. Weekly. 2024 Aug; 73(34):734-9.Texto completo
45. Centers for Disease Control and Prevention. CDC confirms human H5 Bird flu case in Missouri. Sep 2024 [internet publication].Texto completo
46. Centers for Disease Control and Prevention. CDC confirms new human cases of H5 bird flu in California. Oct 2024 [internet publication].Texto completo
47. Centers for Disease Control and Prevention. CDC confirms 3rd human case of H5 bird flu in California. Oct 2024 [internet publication].Texto completo
48. World Health Organization. Avian influenza A(H5N1) - Cambodia. Sep 2024 [internet publication].Texto completo
49. World Health Organization. Avian influenza A (H5N1): Australia. Jun 2024 [internet publication].Texto completo
50. World Health Organization. Disease outbreak news: avian influenza A(H5N1) - Viet Nam. Apr 2024 [internet publication].Texto completo
51. World Health Organization. Disease outbreak news: avian influenza A (H5N1) - Cambodia. Feb 2024 [internet publication].Texto completo
52. World Health Oragnization. Disease outbreak news: avian influenza A (H5N1) - Cambodia. Nov 2023 [internet publication].Texto completo
53. World Health Organization. Disease outbreak news: avian influenza A H5N1 - United Kingdom of Great Britain and Northern Ireland. May 2023 [internet publication].Texto completo
54. World Health Organization. Disease outbreak news: human infection caused by avian Influenza A (H5N1) - Chile. Apr 2023 [internet publication].Texto completo
55. Castillo A, Fasce R, Parra B, et al. The first case of human infection with H5N1 avian Influenza A virus in Chile. J Travel Med. 2023 Sep 5;30(5):taad083.Texto completo Resumo
56. Centers for Disease Control and Prevention. Human infection with highly pathogenic avian influenza A(H5N1) virus in Chile. Mar 2023 [internet publication].Texto completo
57. World Health Organization. Disease outbreak news: avian influuenza A (H5N1) - Cambodia. Feb 2023 [internet publication].Texto completo
58. World Health Organization. Disease outbreak news: human infection caused by avian influenza A(H5) - Ecuador. Jan 2023 [internet publication].Texto completo
59. Bruno A, Alfaro-Núñez A, de Mora D, et al. First case of human infection with highly pathogenic H5 avian Influenza A virus in South America: A new zoonotic pandemic threat for 2023? J Travel Med. 2023 Sep 5;30(5):taad032.Texto completo Resumo
60. World Health Organization. Update: WHO-confirmed human cases of avian influenza A (H5N1) infection, November 2003-May 2008. Wkly Epidemiol Rec. 2008 Nov 14;83(46):415-20. Resumo
61. Le MQ, Horby P, Fox A, et al. Subclinical avian influenza A(H5N1) virus infection in human, Vietnam. Emerg Infect Dis. 2013 Oct;19(10):1674-7.Texto completo Resumo
62. Capelastegui F, Smith J, Kumbang J, et al. Pilot of asymptomatic swabbing of humans following exposures to confirmed avian influenza A(H5) in avian species in England, 2021/2022. Influenza Other Respir Viruses. 2023 Aug;17(8):e13187.Texto completo Resumo
63. Aznar E, Casas I, González Praetorius A, et al. Influenza A(H5N1) detection in two asymptomatic poultry farm workers in Spain, September to October 2022: suspected environmental contamination. Euro Surveill. 2023 Feb;28(8):2300107.Texto completo Resumo
64. Oliver I, Roberts J, Brown CS, et al. A case of avian influenza A(H5N1) in England, January 2022. Euro Surveill. 2022 Feb;27(5):2200061.Texto completo Resumo
65. Qi Y, Ni HB, Chen X, et al. Seroprevalence of highly pathogenic avian influenza (H5N1) virus infection among humans in mainland China: a systematic review and meta-analysis. Transbound Emerg Dis. 2020 Sep;67(5):1861-71. Resumo
66. Gomaa MR, El Rifay AS, Abu Zeid D, et al. Incidence and seroprevalence of avian influenza in a cohort of backyard poultry growers, Egypt, Aug 2015-Mar 2019. Emerg Infect Dis. 2020 Sep;26(9):2129-36.Texto completo Resumo
67. Tong S, Zhu X, Li Y, et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013;9(10):e1003657.Texto completo Resumo
68. Centers for Disease Control and Prevention. Bird flu in animals and people: causes and how it spreads. May 2022 [internet publication].Texto completo
69. Areechokchai D, Jiraphongsa C, Laosiritaworn Y, et al. Investigation of avian influenza (H5N1) outbreak in humans: Thailand, 2004. MMWR Morb Mortal Wkly Rep. 2006 Apr 28;55(1):3-6.Texto completo Resumo
70. Dinh PN, Long HT, Tien NT, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis. 2006 Dec;12(12):1841-7.Texto completo Resumo
71. World Health Organization. Update on human cases of highly pathogenic avian influenza A(H5N1) virus infection, 2011. Wkly Epidemiol Rec. 2012 Mar 30;87(13):117-23.Texto completo Resumo
72. Mounts AW, Kwong H, Izurieta HS, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis. 1999 Aug;180(2):505-8. Resumo
73. Zhou L, Liao Q, Dong L, et al. Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis. 2009 Jun 15;199(12):1726-34.Texto completo Resumo
74. Wan XF, Dong L, Lan Y, et al. Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol. 2011 Dec;85(24):13432-8.Texto completo Resumo
75. Cavailler P, Chu S, Ly S, et al. Seroprevalence of anti-H5 antibody in rural Cambodia, 2007. J Clin Virol. J Clin Virol. 2010 Jun;48(2):123-6. Resumo
76. Kandun IN, Tresnaningsih E, Purba WH, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet. 2008 Aug 30;372(9640):744-9. Resumo
77. Horby P, Sudoyo H, Viprakasit V, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect. 2010 Nov;138(11):1550-8.Texto completo Resumo
78. Human cases of avian influenza A (H5N1) in North-West Frontier Province, Pakistan, October-November 2007. Wkly Epidemiol Rec. 2008 Oct 3;83(40):359-64. Resumo
79. Aditama TY, Samaan G, Kusriastuti R, et al. Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin Infect Dis. 2011 Dec;53(12):1237-44.Texto completo Resumo
80. Aditama TY, Samaan G, Kusriastuti R, et al. Avian influenza H5N1 transmission in households, Indonesia. PLoS One. 2012;7(1):e29971.Texto completo Resumo
81. Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med. 2006 Nov 23;355(21):2186-94.Texto completo Resumo
82. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005 Sep 29;353(13):1374-85.Texto completo Resumo
83. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012 May 2;486(7403):420-8.Texto completo Resumo
84. Centers for Disease Control and Prevention. Study shows ferrets became sick with A(H5N1) virus after eye exposure. Jun 2024 [internet publication].Texto completo
85. Neumann G, Macken CA, Karasin AI, et al. Egyptian H5N1 influenza viruses-cause for concern? PLoS Pathog. 2012;8(11):e1002932.Texto completo Resumo
86. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science. 2012 Jun 22;336(6088):1541-7.Texto completo Resumo
87. Uyeki TM, Bresee JS. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg Infect Dis. 2007 Dec;13(12):1969-71.Texto completo Resumo
88. Refaey S, Azziz-Baumgartner E, Amin MM, et al. Increased number of human cases of influenza virus A(H5N1) infection, Egypt, 2014-15. Emerg Infect Dis. 2015 Dec;21(12):2171-3.Texto completo Resumo
89. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009 Jul 10;325(5937):197-201.Texto completo Resumo
90. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005 Aug;3(8):591-600. Resumo
91. Yamada S, Suzuki Y, Suzuki T, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature. 2006 Nov 16;444(7117):378-82. Resumo
92. van Riel D, Munster VJ, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science. 2006 Apr 21;312(5772):399. Resumo
93. Shu Y, Li CK, Li Z, et al. Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues. J Infect Dis. 2010;201:1173-1177. Resumo
94. Chandrasekaran A, Srinivasan A, Raman R, et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol. 2008 Jan;26(1):107-13. Resumo
95. Auewarakul P, Suptawiwat O, Kongchanagul A, et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol. 2007 Sep;81(18):9950-5.Texto completo Resumo
96. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res. 2005 Nov 11;6(1):135.Texto completo Resumo
97. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006 Oct;12(10):1203-7.Texto completo Resumo
98. Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet. 2007 Sep 29;370(9593):1137-45. Resumo
99. Apisarnthanarak A, Erb S, Stephenson I, et al. Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clin Infect Dis. 2005 Jan 15;40(2):e16-8. Resumo
100. Liem NT, Lim W. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis. 2005 Feb;11(2):210-5.Texto completo Resumo
101. Schultsz C, Dong VC, Chau NV, et al. Avian influenza H5N1 and healthcare workers. Emerg Infect Dis. 2005 Jul;11(7):1158-9.Texto completo Resumo
102. Ortiz JR, Katz MA, Mahmoud MN, et al. Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. J Infect Dis. 2007 Dec 1;196(11):1685-91.Texto completo Resumo
103. World Health Organization. Practical interim guidance to reduce the risk of infection in people exposed to avian influenza viruses. Aug 2024 [internet publication].Texto completo
104. UK Health Security Agency. Management of contacts of highly pathogenic avian influenza H5N1 during the 2023 to 2024 avian influenza season. Feb 2024 [internet publication].Texto completo
105. Prieto-Lara E, Llanos-Mendez A. Safety and immunogenicity of prepandemic H5N1 influenza vaccines: a systematic review of the literature. Vaccine. 2010 Jun 11;28(26):4328-34. Resumo
106. Vesikari T, Forstén A, Herbinger KH, et al. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly. Vaccine. 2012 Feb 8;30(7):1388-96. Resumo
107. Langley JM, Risi G, Caldwell M, et al. Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study. J Infect Dis. 2011 Jun 15;203(12):1729-38.Texto completo Resumo
108. US Food and Drug Administration. Influenza virus vaccine, H5N1 (for national stockpile). Feb 2018 [internet publication].Texto completo
109. Qualls N, Levitt A, Kanade N, et al; CDC Community Mitigation Guidelines Work Group. Community mitigation guidelines to prevent pandemic influenza - United States, 2017. MMWR Recomm Rep. 2017 Apr 21;66(1):1-34.Texto completo Resumo
110. Centers for Disease Control and Prevention. Case definitions for investigations of human infection with avian influenza A viruses in the United States. May 2024 [internet publication].Texto completo
111. World Health Organization. Interim guidelines for avian influenza case management. Sep 2007 [internet publication].Texto completo
112. Centers for Disease Control and Prevention. Interim guidance on specimen collection and testing for patients with suspected infection with novel influenza A viruses associated with severe disease or with the potential to cause severe disease in humans. Sep 2024 [internet publication].Texto completo
113. World Health Organization. Clinical practice guidelines for influenza. Sep 2024 [internet publication].Texto completo
114. European Centre for Disease Prevention and Control. Enhanced surveillance of severe avian influenza virus infections in hospital settings in the EU/EEA. Jun 2023 [internet publication].Texto completo
115. Centers for Disease Control and Prevention. Interim guidance for infection control within healthcare settings when caring for confirmed cases, probable cases, and cases under investigation for infection with novel influenza A viruses associated with severe disease. Mar 2022 [internet publication].Texto completo
116. World Health Organization. Collecting, preserving and shipping specimens for the diagnosis of avian influenza A(H5N1) virus infection. Oct 2006 [internet publication].Texto completo
117. UK Health Security Agency. Laboratory investigations for suspected avian influenza A(H7) and A(H5) human infections in England. 2022 [internet publication].Texto completo
118. UK Health Security Agency. Avian influenza: guidance for managing human cases. Feb 2024 [internet publication].Texto completo
119. Centers for Disease Control and Prevention. Symptom monitoring among persons exposed to HPAI. Jun 2024 [internet publication].Texto completo
120. Centers for Disease Control and Prevention. Interim guidance for follow-up of close contacts of persons infected with novel influenza A viruses associated with severe human disease or with potential to cause severe human disease, and use of antiviral medications for post-exposure prophylaxis. Aug 2024 [internet publication].Texto completo
121. Patel RB, Mathur MB, Gould M, et al. Demographic and clinical predictors of mortality from highly pathogenic avian influenza A (H5N1) virus infection: CART analysis of international cases. PLoS One. 2014 Mar 25;9(3):e91630.Texto completo Resumo
122. Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Dec 2023 [internet publication].Texto completo
123. Adisasmito W, Chan PK, Lee N, et al. Effectiveness of antiviral treatment in human influenza A (H5N1) infections: analysis of a Global Patient Registry. J Infect Dis. 2010 Oct 15;202(8):1154-60.Texto completo Resumo
124. Chan PK, Lee N, Zaman M, et al. Determinants of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis. 2012 Nov;206(9):1359-66. Resumo
125. Duval X, van der Werf S, Blanchon T, et al. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010 Nov 2;7(11):e1000362.Texto completo Resumo
126. Kayali G, Webby RJ, Ducatez MF, et al. The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS One. 2011 Mar 21;6(3):e17730.Texto completo Resumo
127. Fiebig L, Soyka J, Buda S, et al. Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010. Euro Surveill. 2011 Aug 11;16(32):19941.Texto completo Resumo
128. Arabi Y, Gomersall CD, Ahmed QA, et al. The critically ill avian influenza A (H5N1) patient. Crit Care Med. 2007 May;35(5):1397-403. Resumo
129. de Jong MD, Tran TT, Truong HK, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005;353:2667-2672.Texto completo Resumo
130. Le QM, Kiso M, Someya K, et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature. 2005 Oct 20;437(7062):1108. Resumo
131. Le MT, Wertheim HF, Nguyen HD, et al. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PLoS One. 2008 Oct 6;3(10):e3339.Texto completo Resumo
132. Centers for Disease Control and Prevention. Interim guidance on influenza antiviral post-exposure prophylaxis of persons exposed to birds or other animals with novel influenza A viruses associated with severe human disease or with the potential to cause severe human disease. Sep 2024 [internet publication].Texto completo
133. Taylor WR, Thinh BN, Anh GT, et al. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza. PLoS One. 2008;3(10):e3410.Texto completo Resumo
134. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med. 2007 Oct 4;357(14):1450-1.Texto completo Resumo
135. Yu H, Gao Z, Feng Z, et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One. 2008 Aug 21;3(8):e2985.Texto completo Resumo
136. Lee CM, Hudson LD. Long-term outcomes after ARDS. Semin Respir Crit Care Med. 2001 Jun;22(3):327-36. Resumo
137. Ehlenbach WJ, Hough CL, Crane PK, et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA. 2010 Feb 24;303(8):763-70.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal